Table 2.
Relationship of WT1 staining with other clinicopathological variables of 99 advanced serous epithelial ovarian carcinoma patients
| Characteristic | No staining (N = 49) | Staining (N = 50) | p-value |
| 1. FIGO Staging | 0.967 | ||
| III | 42 (85.7) | 43 (86.0) | |
| IV | 7 (14.3) | 7 (14.0) | |
| 2. Histologic grade | 0.610 | ||
| 1 | 32 (65.3) | 28 (56.0) | |
| 2 | 10 (20.4) | 14 (28.0) | |
| 3 | 7 (14.3) | 8 (16.0) | |
| 3. Residual tumor (cm) | 0.009 | ||
| None | 8 (16.3) | 5 (10.0) | |
| >0–≤1 | 2 (4.1) | 6 (12.0) | |
| >1–≤2 | 3 (6.1) | 1 (2.0) | |
| >2 | 18 (36.7) | 32 (64.0) | |
| No data | 18 (36.7) | 6 (12.0) | |
| 4. Chemotherapy response | 0.036 | ||
| Complete | 37 (75.5) | 25 (50.0) | |
| Partial | 3 (6.1) | 5 (10.0) | |
| Stable disease | 4 (8.2) | 4 (8.0) | |
| Progressive disease | 5 (10.2) | 16 (32.0) |